<code id='AAEAE5BCE2'></code><style id='AAEAE5BCE2'></style>
    • <acronym id='AAEAE5BCE2'></acronym>
      <center id='AAEAE5BCE2'><center id='AAEAE5BCE2'><tfoot id='AAEAE5BCE2'></tfoot></center><abbr id='AAEAE5BCE2'><dir id='AAEAE5BCE2'><tfoot id='AAEAE5BCE2'></tfoot><noframes id='AAEAE5BCE2'>

    • <optgroup id='AAEAE5BCE2'><strike id='AAEAE5BCE2'><sup id='AAEAE5BCE2'></sup></strike><code id='AAEAE5BCE2'></code></optgroup>
        1. <b id='AAEAE5BCE2'><label id='AAEAE5BCE2'><select id='AAEAE5BCE2'><dt id='AAEAE5BCE2'><span id='AAEAE5BCE2'></span></dt></select></label></b><u id='AAEAE5BCE2'></u>
          <i id='AAEAE5BCE2'><strike id='AAEAE5BCE2'><tt id='AAEAE5BCE2'><pre id='AAEAE5BCE2'></pre></tt></strike></i>

          
          WSS
          The US Supreme Court silhouetted -- Abortion coverage from STAT
          STEFANI REYNOLDS/AFP via Getty Images

          WASHINGTON — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

          The justices seemed by turns relucant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.

          advertisement

          The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more. The company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          knowledge